Top

Published in:

Open Access 01-12-2009 | Research

Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients

Authors: Lucely Cetina, Alicia Garcia-Arias, Myrna Candelaria, David Cantú, Lesbia Rivera, Jaime Coronel, Blanca Bazan-Perkins, Vladimir Flores, Aaron Gonzalez, Alfonso Dueñas-González

Published in: World Journal of Surgical Oncology | Issue 1/2009

Abstract

Background

A current paradigm in the treatment of cervical cancer with radiation therapy is that intracavitary brachytherapy is an essential component of radical treatment. This is a matched retrospective comparison of the results of treatment in patients treated with external beam chemoradiation (EBRT-CT) and radical hysterectomy versus those treated with identical chemoradiation followed by brachytherapy.

Methods

In this non-randomized comparison EBRT-CT protocol was the same in both groups of 40 patients. In the standard treated patients, EBRT-CT was followed by one or two intracavitary Cesium (low-dose rate) applications within 2 weeks of finishing external radiation to reach a point A dose of at least 85 Gy. In the surgically treated patients, radical hysterectomy with bilateral pelvic lymph node dissection and para-aortic lymph node sampling were performed within 7 weeks after EBRT-CT. Response, toxicity and survival were evaluated.

Results

A total of 80 patients were analyzed. The patients receiving EBRT-CT and surgery were matched with the standard treated cases. There were no differences in the clinicopathological characteristics between groups or in the delivery of EBRT-CT. The pattern of acute and late toxicity differed. Standard treated patients had more chronic proctitis while the surgically treated had acute complications of surgery and hydronephrosis. At a maximum follow-up of 60 months, median follow-up 26 (2–31) and 22 (3–27) months for the surgery and standard therapy respectively, eight patients per group have recurred and died. The progression free and overall survival are the same in both groups.

Conclusion

The results of this study suggest that radical hysterectomy can be used after EBRT-CT without compromising survival in FIGO stage IB2-IIB cervical cancer patients in settings were brachytherapy is not available. A randomized study is needed to uncover the value of surgery after EBRT-CT.

Available only for authorised users

Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322/canjclin.55.2.74.CrossRefPubMed

Green J, Kirwan J, Tierney J, Vale C, Symonds P, Fresco L, Williams C, Collingwood M: Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev. 2005, CD002225-

Morley GW, Seski JC: Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol. 1976, 126: 785-798.PubMed

Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, Favini G, Ferri L, Mangioni C: Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997, 350: 535-540. 10.1016/S0140-6736(97)02250-2.CrossRefPubMed

Stehman FB, Ali S, Keys HM, Muderspach LI, Chafe WE, Gallup DG, Walker JL, Gersell D: Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol. 2007, 197: e1-6. 10.1016/j.ajog.2007.08.003.CrossRefPubMed

Candelaria M, Chanona-Vilchis J, Cetina L, Flores-Estrada D, López-Graniel C, González-Enciso A, Cantú D, Poitevin A, Rivera L, Hinojosa J, de la Garza J, Dueñas-Gonzalez A: Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinoma. Int Semin Surg Oncol. 2006, 3: 3-10.1186/1477-7800-3-3.PubMedCentralCrossRefPubMed

Candelaria M, Cetina L, Garcia-Arias A, Lopez-Graniel C, de la Garza J, Robles E, Duenas-Gonzalez A: Radiation-sparing managements for cervical cancer: a developing countries perspective. World J Surg Oncol. 2006, 4: 77-10.1186/1477-7819-4-77.PubMedCentralCrossRefPubMed

Keys HM, Bundy BN, Stehman FB, Okagaki T, Gallup DG, Burnett AF, Rotman MZ, Fowler WC, Gynecologic Oncology Group: Gynecologic Oncology Group. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol Oncol. 2003, 89: 343-353. 10.1016/S0090-8258(03)00173-2.CrossRefPubMed

Bernard A, Touboul E, Lefranc JP: [Epidermoid carcinoma of the uterine cervix at operable bulky stages IB and II treated with combined primary radiation therapy and surgery]. Cancer Radiother. 2002, 6: 85-98.CrossRefPubMed

10.

Moyses HM, Morrow CP, Muderspach LI, Roman LD, Vasilev SA, Petrovich Z, Groshen SL, Klement V: Residual disease in the uterus after preoperative radiotherapy and hysterectomy in stage IB cervical carcinoma. Am J Clin Oncol. 1996, 19: 433-438. 10.1097/00000421-199610000-00001.CrossRefPubMed

11.

Rouzier R, Morice P, De Crevoisier R, Pomel C, Rey A, Bonnet K, Recoules-Arche A, Duvillard P, Lhomme C, Haie-Meder C, Castaigne D: Survival in cervix cancer patients treated with radiotherapy followed by radical surgery. Eur J Surg Oncol. 2005, 31: 424-433. 10.1016/j.ejso.2005.01.003.CrossRefPubMed

12.

Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, Walker JL, Gersell D: radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999, 340: 1154-1161. 10.1056/NEJM199904153401503.CrossRefPubMed

13.

Noterman D, Philippson C, Hertens D, Veys I, Schobbens JC, Nogaret JM: [Neoadjuvant radiochemotherapy and surgery of locally advanced cervical carcinoma: review of 22 patients treated at the Bordet Institute]. J Gynecol Obstet Biol Reprod (Paris). 2006, 35: 23-27.CrossRef

14.

Resbeut M, Cowen D, Viens P, Noirclerc M, Perez T, Gouvernet J, Delpero JR, Gamerre M, Boubli L, Houvenaeghel G: Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. Gynecol Oncol. 1994, 54: 68-75. 10.1006/gyno.1994.1168.CrossRefPubMed

15.

Houvenaeghel G, Lelievre L, Rigouard AL, Buttarelli M, Jacquemier J, Viens P, Gonzague-Casabianca L: Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer. Gynecol Oncol. 2006, 102: 74-79. 10.1016/j.ygyno.2005.11.037.CrossRefPubMed

16.

Classe JM, Rauch P, Rodier JF, Morice P, Stoeckle E, Lasry S, Houvenaeghel G, Groupe des Chirurgiens de Centre de Lutte Contre le Cancer: Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: Morbidity and outcome: Results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer). Gynecol Oncol. 2006, 102: 523-9. 10.1016/j.ygyno.2006.01.022.CrossRefPubMed

17.

Jurado M, Martinez-Monge R, Garcia-Foncillas J, Azinovic I, Aristu J, López-García G, Brugarolas A: Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer. Gynecol Oncol. 1999, 74: 30-37. 10.1006/gyno.1999.5424.CrossRefPubMed

18.

Mancuso S, Smaniotto D, Benedetti-Panici P, Favale B, Greggi S, Manfredi R, Margariti PA, Morganti AG, Scambia G, Tortoreto F, Valentini V, Cellini N: Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma. Gynecol Oncol. 2000, 78: 324-328. 10.1006/gyno.2000.5862.CrossRefPubMed

19.

Modarress M, Maghami FQ, Golnavaz M, Behtash N, Mousavi A, Khalili GR: Comparative study of chemoradiation and neoadjuvant chemotherapy effects before radical hysterectomy in stage IB-IIB bulky cervical cancer and with tumor diameter greater than 4 cm. Int J Gynecol Cancer. 2005, 15: 483-488. 10.1111/j.1525-1438.2005.15312.x.CrossRefPubMed

20.

Mariagrazia D, Anna F, Gabriella F, Francesco F, Daniela S, Giuseppe D, Alessio M, Giovanni S: Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications. Gynecol Oncol. 2005, 99 (3 Suppl 1): S166-170. 10.1016/j.ygyno.2005.07.074.CrossRefPubMed

21.

Duenas-Gonzalez A, Cetina-Perez L, Lopez-Graniel C, Gonzalez-Enciso A, Gómez-Gonzalez E, Rivera-Rubi L, Montalvo-Esquivel G, Muñoz-Gonzalez D, Robles-Flores J, Vazquez-Govea E, de La Garza J, Mohar A: Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized phase II study. Int J Radiat Oncol Biol Phys. 2005, 61: 817-823.CrossRefPubMed

22.

Cetina L, Rivera L, Hinojosa J, Poitevin A, Uribe J, López-Graniel C, Cantú D, Candelaria M, de la Garza J, Dueñas-González A: Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results. BMC Women's Health. 2006, 6: 3-10.1186/1472-6874-6-3.PubMedCentralCrossRefPubMed

23.

Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958, 53: 457-481. 10.2307/2281868.CrossRef

24.

Mantel M: Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemother Rep. 1966, 50: 163-70.PubMed

25.

Behtash N, Nazari Z, Ayatollahi H, Modarres M, Ghaemmaghami F, Mousavi A: Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer. Eur J Surg Oncol. 2006, 32: 1226-30. 10.1016/j.ejso.2006.07.012.CrossRefPubMed

26.

Dueñas-Gonzalez A, Cetina L, Mariscal I, de la Garza J: Modern management of locally advanced cervical carcinoma. Cancer Treat Rev. 2003, 29: 389-99. 10.1016/S0305-7372(03)00068-9.CrossRefPubMed

27.

Moore DH: Treatment of stage IB2 (bulky) cervical carcinoma. Cancer Treat Rev. 2003, 29: 401-6. 10.1016/S0305-7372(03)00075-6.CrossRefPubMed

28.

Jewell EL, Kulasingam S, Myers ER, Alvarez Secord A, Havrilesky LJ: Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis. Gynecol Oncol. 2007, 107: 532-40. 10.1016/j.ygyno.2007.08.056.CrossRefPubMed

29.

Monk BJ, Solh S, Johnson MT, Montz FJ: Radical hysterectomy after pelvic irradiation in patients with high risk cervical cancer or uterine sarcoma: morbidity and outcome. Eur J Gynaecol Oncol. 1993, 14: 506-511.PubMed

30.

Morice P, Haie-Meder C, Rey A, Pautier P, Lhommé C, Gerbaulet A, Duvillard P, Castaigne D: Radiotherapy and radical surgery for treatment of patients with bulky stage IB and II cervical carcinoma. Int J Gynecol Cancer. 2000, 10: 239-246. 10.1046/j.1525-1438.2000.010003239.x.CrossRefPubMed

31.

Houvenaeghel G, Lelievre L, Buttarelli M, Jacquemier J, Carcopino X, Viens P, Gonzague-Casabianca L: Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma. Eur J Surg Oncol. 2007, 33: 498-503. 10.1016/j.ejso.2006.10.011.CrossRefPubMed

32.

Azria E, Morice P, Haie-Meder C, Thoury A, Pautier P, Lhomme C, Duvillard P, Castaigne D: Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma. Ann Surg Oncol. 2005, 12: 332-7. 10.1245/ASO.2005.05.020.CrossRefPubMed

33.

Dargent D, Lamblin G, Romestaing P, Montbarbon X, Mathevet P, Benchaib M: Effect of radiotherapy on pelvic lymph node metastasis in cervical cancer stages IB2-IVA: a retrospective analysis of two comparative series. Int J Gynecol Cancer. 2005, 15: 468-474. 10.1111/j.1525-1438.2005.15310.x.CrossRefPubMed

34.

Ferrandina G, Distefano M, Ludovisi M, Morganti A, Smaniotto D, D'Agostino G, Fanfani F, Scambia G: Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy. Ann Surg Oncol. 2007, 14: 1129-35. 10.1245/s10434-006-9252-0.CrossRefPubMed

35.

Orr JW, Shingleton HM, Hatch KD: Correlation of perioperative morbidity and conization to radical hysterectomy interval. Obstet Gynecol. 1982, 59: 726-31.PubMed

36.

Hatch KD, Parham G, Shingleton H: Ureteral strictures and fistulae following radical Wertheim hysterectomy. Gynecol Oncol. 1984, 19: 17-23. 10.1016/0090-8258(84)90152-5.CrossRefPubMed

37.

Lopez-Graniel C, Reyes M, Chanona G, Robles E, Mohar A, Lopez-Basave H, De La Garza JG, Dueñas-Gonzalez A: Type III radical histerectomy after induction chemotherapy for patients with locally advanced cervical carcinoma. Int J Gynecol Cancer. 2001, 11: 210-217. 10.1046/j.1525-1438.2001.01012.x.CrossRefPubMed

38.

Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC: Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005, 23: 7428-36. 10.1200/JCO.2004.00.3996.CrossRefPubMed

39.

Barraclough LH, Swindell R, Livsey JE, Hunter RD, Davidson SE: External beam boost for cancer of the cervix uteri when intracavitary therapy cannot be performed. Int J Radiat Oncol Biol Phys. 2008, 71: 772-8.CrossRefPubMed

40.

Logsdon MD, Eifel PJ: Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys. 1999, 43: 763-75.CrossRefPubMed

41.

Georg D, Kirisits C, Hillbrand M, Dimopoulos J, Pötter R: Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys. 2008, 71: 1272-8.CrossRefPubMed

42.

Levin V, Meghzifene A, Izewska J, Tatsuzaki H: Improving cancer care. Increased need for radiotherpay in developing countries. IAEA BULLETIN, 43/2/2001. http://www.iaea.org/Publications/Magazines/Bulletin/Bull432/article6.pdf

43.

Tatsuzaki H, Levin CV: Quantitative status of resources for radiation therapy in Asia and Pacific region. Radiother Oncol. 2001, 60: 81-89. 10.1016/S0167-8140(01)00330-9.CrossRefPubMed

44.

Zubizarreta EH, Poitevin A, Levin CV: Overview of radiotherapy resources in Latin America: a survey by the International Atomic Energy Agency (IAEA). Radiother Oncol. 2004, 73: 97-100. 10.1016/j.radonc.2004.07.022.CrossRefPubMed

Title: Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients
Authors: Lucely Cetina
Alicia Garcia-Arias
Myrna Candelaria
David Cantú
Lesbia Rivera
Jaime Coronel
Blanca Bazan-Perkins
Vladimir Flores
Aaron Gonzalez
Alfonso Dueñas-González
Publication date: 01-12-2009
Publisher: BioMed Central
Published in: World Journal of Surgical Oncology / Issue 1/2009
Electronic ISSN: 1477-7819
DOI: https://doi.org/10.1186/1477-7819-7-19

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2009

Lymphangiosis carcinomatosa in squamous cell carcinomas of larynx and hypopharynx – value of conventional evaluation and additional immunohistochemical staining of D2-40

A rare coexistence of adrenal cavernous hemangioma with extramedullar hemopoietic tissue: a case report and brief review of the literature

Treatment of early uterine sarcomas: disentangling adjuvant modalities

A comprehensive overview of radioguided surgery using gamma detection probe technology

A giant hemolymphangioma of the pancreas in a 20-year-old girl: a report of one case and review of the literature

The combination effect of sodium butyrate and 5-Aza-2'-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines